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Abstract
Background: While viruses have long been shown to capitalize on their limited genomic size by utilizing
both strands of DNA or complementary DNA/RNA intermediates to code for viral proteins, it has been
assumed that human retroviruses have all their major proteins translated only from the plus or sense
strand of RNA, despite their requirement for a dsDNA proviral intermediate. Several studies, however,
have suggested the presence of antisense transcription for both HIV-1 and HTLV-1. More recently an
antisense transcript responsible for the HTLV-1 bZIP factor (HBZ) protein has been described. In this
study we investigated the possibility of an antisense gene contained within the human immunodeficiency
virus type 1 (HIV-1) long terminal repeat (LTR).
Results: Inspection of published sequences revealed a potential transcription initiator element (INR)
situated downstream of, and in reverse orientation to, the usual HIV-1 promoter and transcription start
site. This antisense initiator (HIVaINR) suggested the possibility of an antisense gene responsible for RNA
and protein production. We show that antisense transcripts are generated, in vitro and in vivo, originating
from the TAR DNA of the HIV-1 LTR. To test the possibility that protein(s) could be translated from this
novel HIV-1 antisense RNA, recombinant HIV antisense gene-FLAG vectors were designed. Recombinant
protein(s) were produced and isolated utilizing carboxy-terminal FLAG epitope (DYKDDDDK)
sequences. In addition, affinity-purified antisera to an internal peptide derived from the HIV antisense
protein (HAP) sequences identified HAPs from HIV+ human peripheral blood lymphocytes.
Conclusion: HIV-1 contains an antisense gene in the U3-R regions of the LTR responsible for both an
antisense RNA transcript and proteins. This antisense transcript has tremendous potential for intrinsic
RNA regulation because of its overlap with the beginning of all HIV-1 sense RNA transcripts by 25
nucleotides. The novel HAPs are encoded in a region of the LTR that has already been shown to be deleted
in some HIV-infected long-term survivors and represent new potential targets for vaccine development.
Published: 08 November 2006
Retrovirology 2006, 3:80 doi:10.1186/1742-4690-3-80
Received: 26 June 2006
Accepted: 08 November 2006
This article is available from: http://www.retrovirology.com/content/3/1/80
© 2006 Ludwig et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
Page 2 of 20
(page number not for citation purposes)
Background
Certain viruses employ bidirectional transcription. The
human dsDNA virus, Herpes simplex, produces latency-
associated transcripts that are antisense to a portion of the
regulatory protein, ICP0, mRNA [1]. The human herpes
virus, Varicella zoster, contains bidirectional promoters
for transcription of the DNA polymerase and major DNA-
binding protein mRNAs. These promoters are coordi-
nately activated by a shared site for a cellular transcription
factor, USF[2]. Plant viruses, such as the ssDNA tomato
leaf curl virus, can encode multiple, overlapping open-
reading frames (ORFs) and utilize either strand of the
genomic ssDNA or a complementary DNA intermediate
as templates for transcription [3]. There is evidence for
bidirectional promoters in the hepadnaviruses, wood-
chuck hepatitis virus and the hepatitis B virus[4,5]. The
human hepatitis D virus, which possesses a single, circular
genomic RNA, translates two of its major proteins (hepa-
titis delta antigen(s)) from a complementary anti-
genomic RNA intermediate[6]. The strategy of encoding
genes on either strand of dsDNA, or genomic RNA or
ssDNA and complementary nucleic acid intermediate,
enables viruses to greatly enhance coding capability.
The prevailing model of HIV-1 transcription, however,
has been of a single viral promoter located in the 5' long
terminal repeat (LTR) of the dsDNA proviral intermediate,
which allows transcription to occur only with the produc-
tion of positive-strand polarity transcripts, i.e., sense tran-
scripts. These transcripts are variably spliced and
translated or remain unspliced to allow production of the
HIV-1 proteins and genomic RNA, respectively[7]. Only a
few papers have suggested bidirectional transcription for
HIV-1[8,9]. Michael, et al. found evidence for negative-
strand RNA transcripts in mononuclear cells from 15 HIV-
1 infected patients. They identified a negative-strand pro-
moter in the U3 region (-78 to -172 from the HIV-1 cap
site), and isolated a cDNA from HIV-1 infected cells capa-
ble of encoding an antisense ORF in a region overlapping
the retroviral envelope gene [8]. However, no protein
from this region was isolated.
With the discovery of an antisense gene in the human T-
cell leukemia virus type 1 encoding the HBZ factor that
interacts with other transcription factors, the presumption
that antisense genes in the human retroviruses cannot
exist or matter should be dispelled [10-13]
The possibility of partially overlapping, and bidirectional
HIV-1 promoters is suggested by our discovery of an anti-
sense initiator (HIVaINR) in the TAR region of the viral
LTR (Figure 1A). Initiator elements (INR) were originally
described as alternative core promoter elements to the
TATA box, the highly conserved sequence for RNA
polymerase II transcription initiation [14]. Remarkably,
the HIVaINR is located 18–28 nucleotides downstream
from the usual start site of HIV-1 transcription, and is ori-
ented to promote an antisense transcript that is opposite
in direction and complementary to the beginning ~25
nucleotides of all HIV-1 mRNAs (Figure 1A). The HIV-
aINR complementary sequence matches the proposed
consensus initiator sequence derived by analyzing a series
of mammalian gene initiators and comparing over 500
promoter sequences[15,16]. Because of this homology,
we postulated that if the HIVaINR functioned, it could
indicate the presence of a novel HIV antisense gene
responsible for either an RNA or protein product.
We demonstrate that this HIVaINR functions as an initia-
tion site for antisense RNA transcription in in vitro tran-
scription reactions and in vivo, in human cells that have
stably incorporated the HIV-1 LTR sequences. Using a
recombinant HIV-1 antisense gene-FLAG vector trans-
fected into human cells, we also show that protein prod-
ucts can be translated. Implicit in these results is that
translational recoding event(s) must be occurring because
of the presence of intervening stop codons preceding the
carboxyterminal sequence encoding the FLAG epitope
(DYKDDDDK) used for antibody detection and immu-
noaffinity purification. Finally, we show that affinity-puri-
fied antibody to an internal peptide derived from the HIV
antisense protein (HAPs) sequence specifically recognizes
the expected molecular weight proteins in human HIV+
peripheral blood lymphocyte lysates.
Results
A consensus sequence suggested a HIV-1 antisense initiator 
element
Many eukaryotic promoters contain either a TATA box or
an initiator (INR), or both, as a core promoter element
that serves to direct transcription initiation[17]. The TATA
box functions to direct transcription initiation approxi-
mately 30 base pairs (bp) downstream, whereas an INR is
a sequence motif that encompasses and orients the tran-
scription start site, generally from a conserved internal C
A (+1) [14,16,17]. Importantly, an INR can act independ-
ently to direct the assembly of transcription complexes
that recruit RNA polymerase II. The terminal deoxynucle-
otidyl transferase (TdT) INR determines the position of
the start site of transcription in the absence of other core
promoter elements (ibid, above). Extensive mutagenesis
and analysis of the function of variant sequence INRs sug-
gested an approximate consensus INR of 5' Py Py A (+1)
N T/A Py Py 3' (Figure 1A) (ibid, above). We observed the
presence of a sequence in HIV-1 TAR region DNA,
5'CCAGATCTGAG3', that when reversed,
5'CTCAGATCTGG3', was remarkably similar to the strong
TdT INR consisting of the sequence 5' CTCA+1TTCTGG3'
(Figure 1A)[14]. This reversed HIV-1 sequence also con-
tained the preferred internal CA+1 N T/A and was sur-Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
Page 3 of 20
(page number not for citation purposes)
Identification of an antisense transcript originating from the HIV-1 antisense INR (HIVaINR) Figure 1
Identification of an antisense transcript originating from the HIV-1 antisense INR (HIVaINR). (A) The TAR sequence in HIV-1 
DNA from the cap site (start of sense transcription) to +59 is shown. Sequence comprising the HIVaINR is indicated with a 
heavy overbar and reverse arrow, and this region of sequence (reversed) is compared to the terminal deoxynucleotidyl trans-
ferase (TdT) INR element [14] and the consensus INR[15]. Underlined sites in the HIV-1 TAR DNA indicate location of puta-
tive sense INR elements [19]. (B) Gel-purified DNA templates used for the generation of transcripts from the HIV-1 promoter 
and the HIVaINR. The original template is labeled "O" (650 bp) and contains the entire LTR from U3 through the PBS. Two 
additional truncated templates are designated "A"(270 bp) and "B"(350 bp). (Not to scale.) The primers U3, AvaII, and AvaI 
(forward arrows) and 510–530 (reverse arrow) are indicated above the original template (O). (C) Primer extension of purified 
RNA generated in vitro using the above HIV-1 LTR templates and Drosophila embryo nuclear extracts. cDNA products were 
produced from an antisense RNA annealing to a biotinylated sense 5'AvaI primer (213 bp, lanes 1 and 2) or biotinylated sense 
5'AvaII primers (274 bp, lanes 5 and 6), but not with a biotinylated sense 5'U3 primer (lane 3), as demonstrated by denaturing 
PAGE, Southern transfer and colorimetric detection (method adapted from U.S. patents 5,900,358; 5,919,677; 6,392,029). The 
same RNA samples were analyzed for the presence of HIV-1 sense transcripts using a biotinylated antisense primer (3'510–
530) (lanes 8–14 correspond to lanes 1–7, respectively), but yielded no transcripts of the expected size (97 bp). This experi-
ment was performed three times with the same results. M lanes received biotinylated ¡-X174 markers with bands from 24–460 
bp shown. NT = no template control.
A.  TAR REGION DNA
CAP
5’GGGTCTCTCT GGTTAGACCA GATCTGAGCC
  TGGGAGCTCT CTGGCTAACT AGGGAACCC 3’ Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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rounded by several pyridimines (C,T), shown by
mutational and experimental analysis to function as INR
elements and matching the loose, but consistent consen-
sus INR (Figure 1A) (ibid, above). Because an INR also
imparts directionality to the recruited transcriptional
complex, as well as directing the start site for transcrip-
tion, the HIV-1 antisense INR (HIVaINR) sequence, 5'
AGATCTGAG3' could be predicted to indicate an initia-
tion site for transcription in the opposite direction, or
antisense that of usual HIV-1 transcription. Inspection of
this HIVaINR sequence in TAR revealed that it was com-
pletely conserved in the 20 B strain HIV-1 complete
genomes listed[18]. We were therefore interested to exam-
ine whether this site functioned as a region of transcrip-
tion initiation in the context of adjoining promoter
sequences in the LTR. Inasmuch as genes can be responsi-
ble for either RNA or RNA/protein products, this could be
the signal for a novel antisense gene within the HIV LTR.
Detection of the antisense transcript in in vitro 
transcription reactions
The HIV-1 LTR contains three putative initiator (INR) ele-
ments within the first 50 bp of the R region or TAR DNA
(Figure 1A). Two INRs previously described are oriented
in the sense direction and are located at the cap site and
downstream of the transcription start site (Figure 1A,
underlined)[19]. The HIV-1 TATA box is upstream of
these two INRs and would be expected to enhance the
functioning of even a weak INR element. The HIVaINR is
located inbetween these two sites, but is oriented to start
transcription in the opposite direction (Figure 1A, over-
bar, reverse arrow). We examined whether antisense tran-
scripts were specifically produced off the HIV-1 LTR using
an in vitro transcription reaction system (Figure 1, and
described in U.S. patent 5,919,677). A variety of truncated
fragments of the HIV-1 LTR were used as templates in
these in vitro transcription reactions (diagrammed in Fig-
ure 1B, and not shown). Drosophila nuclear extracts con-
tain RNA polymerases and transcription factors
previously shown to interact effectively with INR elements
and were used in the transcription reactions with the LTR
templates[20,21]. Primer extension or RNase digestion
was used to map the origins of the purified RNAs synthe-
sized in vitro from the designated HIV-1 LTR templates
(Figure 1B, 1C). The expected size cDNA following primer
extension for an antisense transcript originating from the
HIVaINR was clearly identified using two separate biotin-
labeled primers, as shown in Figure 1C (lanes 1,2, or 5,6
with the expected size products of 213 and 274 bp, respec-
tively). As a control, the same in vitro synthesized and
purified RNA samples were simultaneously assayed for
sense RNA transcripts by primer extension and no cDNA
product was observed (Figure 1C: lanes 8–10,12,13:
expected size product would be 97 bp). Thus the putative
sense orientation INR elements were not functioning in
this system. However, they can be viewed as mutant inter-
nal control INRs within the same LTR DNA with the
sequence surrounding the HIV-1 transcription start site,
5'CTGGGTCT 3', and at a site 37 nucleotides from the
start site with the sequences 5'CTCTCTGG 3' (Figure 1A,
brackets)[19]. Except for a 3 bp internal deletion, the lat-
ter sequence is identical to the reversed HIVaINR (Figure
1A). Additional controls included reactions with no tem-
plate (NT) and no nuclear extract (lanes 7 and 14) or sim-
ply no template (lane 4), in which only the biotinylated
primer was detected (Figure 1C). This indicated that the
nuclear extract was not contributing any of the product
bands observed.
These results suggested a preferential accumulation of the
Drosophila transcription factors (and RNA polymerase) at
the HIVaINR over the two putative sense INRs and identi-
fied for the first time a novel antisense promoter element
within HIV-1 TAR region DNA. In addition, these experi-
ments identified a single HIV antisense transcript originat-
ing from the region of the HIVaINR. If there had been
multiple initiation sites off the R-U3 regions of the LTR,
one would have expected to see additional product bands
in these experiments. No additional bands suggesting
alternative start sites were observed with any of the HIV-1
LTR templates studied. RNase digestion, performed simul-
taneously with primer extension, confirmed these results
(not shown). These experiments also revealed that the 3'
end of the antisense transcript in the same samples was
not detected by the complementary U3 primer (Figure 1C,
lane 3).
Detection of the HIV-1 antisense transcript in vivo, in 
human cell lines that were either transiently transfected or 
stably transfected with the HIV-1 LTR
The more telling question was whether HIV-1 antisense
transcription could be detected in vivo with human cells
susceptible to infection by HIV-1. In many previous sys-
tems it has been difficult to detect the presence of anti-
sense transcripts in vivo despite apparent biological
effects[22]. In preliminary experiments to determine the
appropriate primers for use in RT-PCR, we used transient
transfection of HIV-1 LTR-containing plasmids or controls
into human Jurkat T cells (see additional File 2 (Figure 2S)
from U.S. patent 6,392029). We had to redesign primers
several times before finding regions that were specific only
for the HIV LTR, and that did not also pick up intrinsic cel-
lular sequences because of the shared transcription factor
binding sites (not shown). For instance, primers overlap-
ping the transcription factor binding site SP1 or the HIV-
aINR within the LTR also detected intrinsic cellular
sequences, presumably because of the many human cellu-
lar genes also containing SP1 or INR sites (not shown).
One of the primer sites that reliably detected only the anti-
sense transcript was the complementary Ava I primer,Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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used during the reverse transcription step (Figure 4).
However, this site represents a region of considerable
sequence heterogeneity in the HIV LTR and needed to be
specifically designed with the HIV-1 strain in mind[18].
The second primer 441 was biotin-labelled and was added
during the polymerase chain reaction (PCR). Biotin-
labelled 441 was derived from sequence following the ini-
tial 5' terminal hairpin of the HIV-1 antisense transcript
(Figure 4). This non-radioactive labelling modification of
RT-PCR enhanced the sensitivity and specificity of detec-
tion (Figure 2B and Additional File 2). We employed rig-
orous internal controls for the RT-PCR, and compared the
same total RNA samples following DNase treatment or
DNase and RNase treatment, in order to ensure that we
were studying RNA, and not a DNA contaminant.
Many experiments indicated that the HIV-1 antisense
RNA transcript is constitutively produced, with two exam-
ples given here (Figure 2B, and additional File 2). A single
expected product band of 183 bp was observed following
RT-PCR of purified RNA from Jurkat T cells transfected
with pHIV-CAT vector containing the HIV-1 LTR (addi-
tional File 2, lanes 7a–12a)[23]. It was only observed with
pHIV-CAT transfected cell RNA, but not mock transfected
(no template, NT) or control Jurkat T cell RNA (additional
File 2, lanes 1a–6a) indicating that intrinsic cellular RNA
was not being detected. The expected product band was
also only observed when the Jurkat T cells transfected with
the HIV-1 LTR vector were amplified with the Ava 1
primer and the biotin-labeled 441 primer, but not with
the Ava 1 primer and a biotin-labeled Mae 1 primer (addi-
tional File 2, compare lanes 7a–12a with 7b–12b). This
indicated that the antisense RNA was initiating in the
region of the HIVaINR inbetween the Mae 1 and 441 site
as expected (diagrammed in Figure 2A). This also showed
that the RNA samples were not contaminated with DNA
from the transfected LTR vector (which would contain the
Mae 1 site). Thus the HIV-1 antisense RNA originated
between these two primer sites, situated 24 nucleotides
apart in the HIV-1 TAR region DNA.
The HIV antisense transcript also initiated from the region
of the HIVaINR in the stably-transfected U38 cells at levels
comparable to or greater than HIV-1 sense transcripts in
the absence of the HIV-1 Tat protein, as illustrated in Fig-
ure 2B. U38 is a human U937 derivative cell line contain-
ing stably integrated copies of the HIV-1 LTR promoter
linked to the CAT gene[24]. The expected 183 bp size
product band was observed with the HIV antisense RT-
PCR (figure 2B, upper panel, arrow labeled as+). As well,
HIV sense transcripts were produced in this cell line as
indicated by the expected 283 bp product band in U38
RNA samples (HIV sense RT-PCR (figure 2B, lower panel).
After stimulation with calcium ionophore and phorbol
myristate ester (PMA), some increment in both sense and
antisense transcription is observed (Figure 2B, *U38, Stim
+). However, along with stimulation (and the production
of more HIV-1 sense transcripts) additional antisense RT-
PCR product bands are observed indicative of autoprim-
ing. One of these additional bands at 312 bp would be
expected if the HIV-1 antisense RNA transcript extended
from a 5' terminal hairpin to a predicted pseudoknot
structure, for instance [25]. All primers were functioning
effectively, as demonstrated by the RT-PCR Internal Stand-
ard RNA (IS+) controls, included in each analysis, as well
as by PCR + controls (Figure 2B). The primers were not
contaminated with template, as shown by the identical
reaction mixtures receiving primer alone (labelled pr, Fig-
ure 2B). RNase treatment of the U38 RNA samples elimi-
nated all the RT-PCR product bands, whether following
HIV antisense RT-PCR or sense RT-PCR (Figure 2B,
labelled RNase +). This confirmed the authenticity of the
RNA synthesized in vivo, and analyzed by RT-PCR. The
quality of the total RNA was also monitored by simultane-
ous analysis RT-PCR for intrinsic cellular G3PDH RNA
transcripts, and additional controls performed included
no reverse transcriptase added, and DNA contamination
controls in each RT-PCR analysis (not shown). Similar
results were obtained with BF24, a monocyte cell line that
had been stably transfected with the HIV-1 LTR linked to
the CAT gene, or with a cell line containing an HIV-1 trun-
cated provirus, HL2/3, following transfection with pHIV-
CAT [23,24].
Translations of HIV-1 putative antisense ORF(s)
There were three possible start sites for translation from
the intrinsic antisense RNA produced utilizing the HIV-1
LTR as template (Figure 3 and Figure 4). Each transla-
tional start was in a separate reading frame and contained
at least one presumptive stop codon (diagrammed as a
filled box, Figure 3). A short ORF initiating from an inter-
nal AUG could encode an 81 aa protein, if a +1 ribosomal
frameshift occurred (Figure 3c and discussed in U.S. pat-
ent 6,392,029). The initial AUG encountered on the anti-
sense RNA could initiate translation in another reading
frame, and with a +1 ribosomal frameshift would generate
a 105 aa protein (diagrammed in Figure 3b). Translation
could also conceivably initiate at a CUG start codon as has
been described for human fibroblast growth factor 2 [26].
Initiation of translation from non-AUG codons has also
been described for HTLV-1[27]. This reading frame would
generate a 108 aa protein in the wild-type virus and con-
tained an early TGA stop codon (Figure 3a). The predicted
amino acid sequences from each translation are shown in
Figures 3 and 4. Translational recoding events such as
read-through or ribosomal frameshifting through a stop
codon are already utilized by retroviruses, including HIV-
1 [7,28,29]. HIV-1 employs translational recoding in
order to translate the gag-pol precursor polyprotein. In
addition, given the appropriate downstream RNA struc-Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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Comparison of antisense RNA transcripts generated in vivo from the HIVaINR with HIV-1 sense transcripts in the absence of  Tat protein Figure 2
Comparison of antisense RNA transcripts generated in vivo from the HIVaINR with HIV-1 sense transcripts in the absence of 
Tat protein. (A) Map of landmarks in the HIV-1 LTR and the relative location of primers used for RT-PCR (not to scale). The 
DNA template used to synthesize the HIV-1 sense and antisense RNA internal standard IS+ is also diagrammed. (B) Analysis of 
in vivo transcripts from U38 cells, which have stably incorporated HIV-1 LTR-CAT sequences, clearly demonstrates intrinsic 
antisense RNA transcripts. Total RNA was obtained from U38 cells grown with and without transient stimulation with PMA 
and Ca ionophore (Stim +/-). U38 RNA samples were split and subjected to DNase treatments or DNase and RNase treat-
ments, as indicated. Each sample was then analyzed by non-radioactively labeled RT-PCR for the presence of HIV-1 antisense 
RNA (expected product 183 bp) and for the presence of HIV-1 sense transcripts (expected size product 285 bp). Each set of 
RT-PCR reactions also included a titration of the internal standard IS+ RNA subjected to the identical RT-PCR reaction, as 
well as a primer alone control (pr), in which no RNA template was added. The IS+ titration is indicated above the lanes. Addi-
tional band(s) in the HIV antisense RT-PCR with stimulation (+) could represent antisense RNA self-primed with a 5' terminal 
hairpin and extending to predicted pseudoknot motifs (expected size 312, ~500). M lanes received biotinylated ø-X174 HinfI 
markers with bands from 24–726 bp in size. Triplet open arrowheads indicate 311, 249, and 200 bp in M, with the single arrow 
indicating antisense RT-PCR product (labeled as+) and single arrowhead indicating sense RT-PCR product (labeled s+). PCR + 
and – lanes received pHIV-CAT or no template with the same primers used for the corresponding RT-PCR. This analysis was 
performed in triplicate with similar results.Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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Diagram and predicted amino acid sequences of HIV-1 antisense proteins (HAPs) Figure 3
Diagram and predicted amino acid sequences of HIV-1 antisense proteins (HAPs). Discussed in text. Sites were detected using 
ScanProsite Tool [66]. HAP peptide 4041 and FLAG aa sequences are underlined.
(a)WT-NY5:LLICSIXGLATPQSRPGHTSLESPQRKVPCRKLDVSSLCSTPDAALGPCDEMLGGCQ
 HAP-FLAG:LLICSIXGLATPQSRPGHASLESPQRKVPCNKLDVNSSXSTPDAALGPRDEMLGGCQ
WT-NY5:   TSTLILLPPGPPSHAGSXGVTSCCSLLHWPLLPALAQLVLTXSTIQRSVDI
HAP-FLAG: TSTLTLLSQGHPFHAGSQGVTSWCSLLYWPLLPYLAQLVLACSTIQRSVDIKLIDTVD
    LEDYKDDDDK
(b)WT-NY5:MQHLRARHSPVPPRPHLPGKSPAESPL(+1)RKLDVSSLCSTPDAALGPCDEMLGGCQ
HAP-FLAG: MQHLRARHSPVPPRPRLPGKSPAESPL(+1)NKLDVNSSXSTPDAALGPRDEMLGGCQ
WT-NY5:   TSTLILLPPGPPSHAGSXGVTSCCSLLHWPLLPALAQLVLTXSTIQRSVDI
HAP-FLAG: TSTLTLLSQGHPFHAGSQGVTSWCSLLYWPLLPYLAQLVLACSTIQRSVDIKLIDTVD
    LEDYKDDDDK
(b)WT-NY5: MQHLRARHSPVPPRPHLPGKSPAESPLXKARCQQSLXYSGCSSRAMXRNARR
HAP-FLAG:  MQHLRARHSPVPPRPRLPGKSPAESPLXQARCQQFLKYSGCSSRATXXNARR
WT-NY5:   LSNFHTNTSPSGSSIPCWLIGCNKLLFSPSLASSTCPGSTGTNLKHHPKVSGYLIPGPGV
HAP-FLAG: LSNLHSNTSLSGSSIPCRLTGCNKLVFSPLLASSTLSGSTGTSLX
(c)WT-NY5: MSAVFVVLRMQLSGHVTKC(+1)RRLSNFHTNTSPSGSSIPCWLIGCNKLLF
HAP-FLAG:  MSTVLEVLRMQLSGHVMKC(+1)RRLSNLHSNTSLSGSSIPCRLTGCNKLVF
WT-NY5:    SPSLASSTCPGSTGTNLKHHPKVSGYLIPGPGV
HAP-FLAG:  SPLLASSTLSGSTGTSLXRetrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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Diagram of antisense RNA derived from NY5 sequences originating from the HIVaINR, along with predicted amino acid  sequence(s) Figure 4
Diagram of antisense RNA derived from NY5 sequences originating from the HIVaINR, along with predicted amino acid 
sequence(s). The sequence varies from that of the HIV antisense gene inserted into HIV-AS-FLAG vector at the nucleotides 
indicated with a dot, and the alternative HAP amino acid is also indicated (discussed in text). Sites of postulated +1 ribosomal 
frameshifting are indicated with *. Stop codons are underlined and in the amino acid translation indicated with (X). The amino 
acids comprising the 4041 peptide are boxed, and the primers used for HIV antisense RNA detection are indicated (dashed 
arrows). Not shown is the run of four-five U bases embedded in a GC rich region encoded at the U3 terminus, which could 
potentially function as a termination signal (for either RNA polymerase 11 or 111) for this antisense RNA (compare B clade 
WEAU, or JRCSF with NY5) [18].Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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ture, the TGA codon may actually code for selenocysteine
[30]. The HIVaINR antisense RNA, in addition to a 5' ter-
minal hairpin (Figure 4), has very extensive structure by
Mfold analysis (not shown). Secondary/tertiary RNA
structure of this intrinsically produced antisense RNA was
already suggested by the RT-PCR experiments (Figure 2
and not shown). The presence of RNA structures such as
hairpins or pseudoknots would suggest an inherent plas-
ticity available for translational decoding [25,28,29].
Proteins are translated from intrinsic HIV-1 antisense gene 
sequences inserted into a recombinant vector
The HIV-1 antisense gene sequence from +14–368 con-
sisting of 354 bp was introduced, with no modifications,
into a recombinant vector encoding an epitope tag
sequence, DYKDDDDK, or FLAG (diagrammed in Figure
5A). Expression of FLAG, situated at the carboxyterminal
end of the recombinant HIV-1 antisense gene-FLAG
fusion protein would indicate RNA and protein prod-
uct(s) were synthesized. The vector, itself, contains no
productive signal for translation initiation upstream of
FLAG, such that translation must initiate off RNA contain-
ing the inserted HIV-1 antisense gene sequences (Figure
4). Two vector constructs were made: one with the HIV-1
antisense gene linked to the carboxyterminal FLAG
sequences (HIV-AS-FLAG), and a negative control vector
with the same HIV-1 sequences in the opposite orienta-
tion, corresponding to nucleotides 87–441 of the LTR
(REV) (Figure 5A). These two constructs, the empty vector
as an additional negative control (-), or a control vector
containing irrelevant DNA but the same pCMV-FLAG vec-
tor (C) used in construction of HIV-AS-FLAG or REV were
separately transfected into HL2/3 cells. HL2/3 cells con-
tain a molecular clone of HIV-1, HXB2/3 gpt, and express
Gag, Env, Tat, Rev, and Nef, but not reverse transcriptase
[31]. This cell line used in these experiments did not syn-
thesize antisense RNA by RT-PCR and the HL2/3 proviral
LTR was truncated by PCR analysis (data not shown).
Because of the requirement for the HIV-1 Tat and Rev pro-
teins for efficient transcriptional elongation and nuclear
export for HIV-1 mRNAs, it was presumed these were also
necessary to enable production of the HIV-1 antisense
proteins. Following simultaneous control and HIV-AS-
FLAG transfections, the cells were washed, lysed, and the
lysate proteins were immunoaffinity-purified using
mouse monoclonal anti-FLAG Ab (M2) affinity columns
or resin split between lysate samples. The transfected
lysate eluates were then concentrated.
Figure 5 demonstrates HAPs production. Given the finite
HIV-1 DNA sequence of 354 bp of the HIV antisense gene
inserted inbetween the CMV promoter of the vector and
the multiple termination signals following the carboxyter-
minal FLAG sequences, the larger protein species selected
on anti-FLAG Ab affinity resins can only be explained by
multimerization. The choice of affinity tag, such as Myc,
FLAG, or histidine, can strongly influence the oligomeri-
zation state of the resulting recombinant protein [32].
Oligomerization of HAPs was confirmed by Western blot-
ting of the concentrated HIV-AS-FLAG eluates (Figure 5D,
labeled anti-FLAG). Immunodetection of FLAG epitopes
specifically identified proteins migrating as 53–54, 31–
32, 27–28, and 24–25 kDa molecular mass bands, as well
as fainter species ≈ 49, 44, and < 20 kDa. These were con-
sistent with two of the predicted HAPs that contained the
carboxyterminal FLAG epitope (diagrammed in Figure 3a
and 3b). The expected molecular mass of the recombinant
HIV-1 antisense protein including the FLAG epitope
(AUG start) is ≈ 13.3 kDa; a dimer, trimer and tetramer
would have a expected molecular mass ≈ 26,6, 39.9 and
53.2 kDa, respectively. The recombinant protein utilizing
a CUG start would yield multimers of 13.7 kDa at ≈27.4,
41.1, and 54.8 kDa. The dimer and tetramer-sized molec-
ular masses (migrating at 27–28 and 53–54 kDa) were
especially prominent bands on multiple Westerns of HIV-
AS-FLAG affinity-purified proteins probed with the
directly-labelled mouse monoclonal antibody to the
FLAG epitope (DYKDDDDK) (Figure 5D, anti-FLAG). To
further add to the complexity, hetero-oligomerization
could occur between the two larger HAP proteins (Figure
3a and 3b), or alternatively, between one of the larger
HAP proteins (3a or 3b) and the shortest protein dia-
grammed in Figure 3c. The 81 amino acid protein pre-
dicted in the WT sequence of molecular mass 8.5 kDa
would be slightly altered at the carboxyterminal end
because of the recombinant vector sequences and is not in
frame with the FLAG sequences. However, hetero-oli-
gomerization between a and c (Figure 3) would yield
dimer and tetramer forms of predicted 22 and 44 kDa
molecular mass, respectively, which were bands repeat-
edly observed along with the 27–28 and 53–54 kDa spe-
cies, both on silver-stained gels of HIV-AS-FLAG
immunoaffinity-purified samples and, more faintly, on
the anti-FLAG immunodetection (Figure 5D, anti-FLAG).
Of more particular significance is the prominent immun-
odetection of these same 44 and 54 kDa molecular mass
proteins isolated from HIV-AS-FLAG immunoaffinity-
purified samples on Western analysis by immunoglobulin
purified from the sera of AIDS patients but not normal
sera (Figure 5D, labelled AIDS sera and NORMAL sera).
Analysis of the immunoaffinity-purified HIV-AS-FLAG
transfected cell lysates and control lysates was performed
on a variety of gel types. These included Tris-glycine SDS-
PAGE and Tris-Tricine-SDS-PAGE with the inclusion of 8
M urea in an attempt to adequately resolve the molecular
masses of the proteins/polypeptides under 60 kDa in size
(Figure 5B, mini-gel apparatus and 5C, large gel appara-
tus) [33,34]. Even following reduction with dithiothreitolRetrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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HIV-1 antisense gene proteins (HAPs) are translated within human cells Figure 5
HIV-1 antisense gene proteins (HAPs) are translated within human cells. (A) Schematic diagram of recombinant vector con-
taining the HIV-1 antisense gene sequences linked to carboxyterminal sequences encoding a FLAG epitope (HIV-AS-FLAG), 
or the same HIV-1 sequences in the opposite orientation linked to the same vector (REV). Landmarks in the HIV-1 LTR U3 
region are not to scale. (B) HL2/3 cells were transfected with HIV-AS-FLAG, mock transfected (-), or transfected with the 
identical vector containing a luciferase gene linked to FLAG (+), and the cell lysates incubated on anti-FLAG immunoaffinity 
columns. Following incubation of the three lysates, each column was washed, and then "batch eluted". The eluates were then 
PEG concentrated and analyzed using Tris-tricine-urea SDS-PAGE with a mini-gel apparatus, followed by silver staining. MM is 
Multi-Mark multi-colored standard (Invitrogen). (C) HIV-AS-FLAG or REV (-) control transfected-cell lysates were incu-
bated on anti-FLAG immunoaffinity columns, and the concentrated, pooled eluate fractions analyzed by Tris-tricine-urea SDS-
PAGE (large gel apparatus) and silver staining. The HIV-AS-FLAG eluates were treated with DTT, with DTT and iodoaceta-
mide (D/I), or received no treatment (NT), as indicated. E, empty; M, Mark 12 protein standard (Invitrogen). (D) Immunoblot 
analysis of HIV-AS-FLAG transfected cells. Cell lysates from HL2/3 cells transfected with HIV-AS-FLAG were affinity-purified 
over anti-FLAG M2 antibody resins, and the eluates were then concentrated (AS-FLAG). The eluates were split and sub-
jected to either no treatment (NT) or treatment with DTT and Iodacetamide (D/I), and then analyzed using Tris-tricine-urea 
SDS-PAGE with a mini-gel apparatus, blotted to nitrocellulose membranes and probed with either AIDS sera, normal serum, 
or biotin-labeled mouse monoclonal anti-FLAG M2 antibody, as indicated. M, MultiMark multi-colored standard (Invitrogen). 
Molecular weights are in kilodaltons.Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
Page 11 of 20
(page number not for citation purposes)
(DTT) and alkylation with iodacetamide (Figure 5C, 5D,
labelled D/I), the proteins remained highly oligomerized,
possibly secondary to the FLAG tag, although the smaller
predicted 13–14 kDa protein band was now observed
(faintly) (Figure 5B, HIV-AS-FLAG). Control lysates from
HL2/3 cells undergoing mock transfection (-), transfec-
tion with an irrelevant DNA/pCMV vector control (C)
(Figure 5D), or transfection with the REV vector control
(Figure 5C) did not produce any protein bands following
immunoaffinity isolation, even with concentration in
PEG (Figure 4B, 4D), providing the M2 affinity gel was
performing adequately. This indicated that the HL2/3 cell
line used in the transfection experiments detailed herein
was not intrinsically capable of producing the HIV-AS-
FLAG fusion protein(s) isolated on the M2 anti-FLAG
antibody resins.
To further identify HIV-1 antisense proteins (HAPs) in
HIV-1 infected human cells, which would not have an
epitope tag, it was imperative to develop antisera that
would recognize HAP(s) internal peptide sequences. We
had peptides synthesized, based on the derived amino
acid sequences for HAPs, for immunization of rabbits, to
enable testing of whether HIV antisense proteins were
intrinsically produced by wild-type virus in human cells.
Peptides were synthesized from immunogenic regions of
each of the proposed translation products indicated in
Figure 3 (arrowheads). One peptide, designated 4041
(amino acid sequence underlined in Figure 3 and boxed
in Figure 4) was particularly successful in inducing anti-
bodies in rabbits. Polyclonal rabbit antisera from two rab-
bits immunized with the 4041 peptide was affinity-
purified over a 4041 peptide-linked column (Biosource).
The affinity-isolated anti-4041 Ab reacted specifically with
the 4041 peptide, but not a control peptide on dot blot
and Western blot analysis (compare lane 5 (4041 peptide
(+)) and lane 6 (4040 peptide (-)) Figure 6, Figure 7D). In
addition, on Western blot analysis the anti-4041 Ab rec-
ognized protein bands migrating as 28–30 and 53–54
kDa molecular mass species from HIV-AS-FLAG trans-
fected cells that had been affinity-purified on the M2 anti-
FLAG Ab column and PEG concentrated but not the
pCMVTag4A empty vector control-transfected HL2/3 pro-
teins that had also been affinity-purified and PEG concen-
trated (compare lanes 1 and 2, Figure 6). Thus the affinity-
purified proteins from the recombinant HIV antisense
gene transfected cells, but not control transfected cells
were recognized three ways by immunodetection on
Western blots: the 53–54 kDa species was recognized by
AIDS sera but not normal sera, by biotin-labelled mouse
monoclonal antibody to the (entire) FLAG epitope, and
by affinity-purified rabbit antibody to an internal HAP
epitope, 4041. The latter two antibodies also recognized a
27–28 kDa species in affinity-purified HIV-AS-FLAG
transfected proteins on these same blots.
Identification and isolation of HAPs in human HIV+ 
peripheral blood lymphocytes (PBLs)
The directly biotin-labelled, affinity purified antibody to
the internal HIV-1 antisense protein peptide 4041 was
then used to probe human PBL cell lysates following 4–
20% tris-glycine SDS-PAGE gel electrophoresis and trans-
fer to membranes (Figure 7A, labelled B-4041 Ab). As a
control, biotin-labelled rabbit anti-keyhole limpet hemo-
cyanin (KLH) antibody was used in tandem to probe the
same cell lysates (Figure 7A, labelled B-KLH Ab). This was
a necessary control because the human lymphocyte cell
lysates undoubtedly contained immunoglobulins (Ig)
and other Ig-binding proteins. These would be capable of
interacting with the immunoblotting antibody detection
system following the renaturation that occurs upon trans-
Antibody to an internal peptide (4041) of HIV antisense pro- teins detects proteins from HIV-AS-FLAG transfected cells,  but not control-transfected cells on western blot analysis Figure 6
Antibody to an internal peptide (4041) of HIV antisense pro-
teins detects proteins from HIV-AS-FLAG transfected cells, 
but not control-transfected cells on western blot analysis. 
Polyclonal rabbit antisera from rabbits immunized to peptide 
4041 was affinity-purified over a 4041 peptide column (Bio-
source) and then used in immunoblot analysis. Peptide 4041 
(+ control, lane 5), peptide 4040 (- control, lane 6), HIV-AS-
FLAG transfected HL2/3 cell lysate (lane 3), and FLAG-affin-
ity isolated eluates from HIV-AS-FLAG transfected (lane 2) 
vs empty vector transfected HL 2/3 cells (lane 1) were sepa-
rated on Tris-tricine-urea SDS-PAGE, transferred to nitro-
cellulose membranes and the blots probed with anti-4041 
antibody. M, MultiMark multi-colored standard. Molecular 
weights are in kilodaltons.Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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Detection and isolation of HAPs in human HIV+ peripheral blood lymphocytes (PBL) with antibody to an internal HAP peptide  (4041) Figure 7
Detection and isolation of HAPs in human HIV+ peripheral blood lymphocytes (PBL) with antibody to an internal HAP peptide 
(4041). (A) Patients HIV (+) PBL 2–5 or HIV (-) PBL-1 cell lysates were fractionated by 4–20% tris-glycine SDS-PAGE and ana-
lyzed by Western blot with biotin-labeled rabbit anti-KLH antibody (B-KLH Ab) and with biotin-labeled rabbit anti-4041 anti-
body (B-4041 Ab). M, MultiMark multi-colored standard. (B) Cell lysates from HIV (+) PBL 5 were analyzed in replicate on 4–
20% tris-glycine SDS-PAGE followed by Western blot using biotin-labelled rabbit anti-4041 Ab, or rabbit anti-p24 Ab, HIV Ig 
(labeled AIDS) and normal human sera, followed by biotin-labelled anti-rabbit Ig or anti-human Ig. (C) HIV (+) PBL 5 lysate was 
fractionated in the presence of 2 ME (as reducing agent) by 4–20% tris-glycine SDS-PAGE, transferred to membrane and 
probed with biotin-labeled anti-4041 Ab in the presence (+) or absence (-) of normal rabbit serum. M, MultiMark multi-colored 
standard. (D) The specificity of the anti-4041 Ab is demonstrated on immunodetection of the + peptide (4041), but not an 
unrelated peptide (4040, -). In the left panel, the anti-4041 Ab is used in immunoblotting detection of the peptides run in the 
gel and transferred to membrane. In the right panel, the anti-4041 Ab (lane 1) or unrelated antibodies (lanes 2,3) are separated 
on SDS-PAGE, transferred to membrane, and then probed with the biotin-labeled peptides, as indicated. (E) Cell lysates from 
HIV (-) PBL 1 were analyzed in replicate on SDS-PAGE followed by Western blot using rabbit anti-4041 Ab, rabbit anti-p24 Ab, 
HIV Ig (labeled AIDS) and normal human sera, as in (B). (F) Affinity-isolation of human (HIV +) PBL 5 cell lysates with HAP pep-
tide 4041-specific antibody linked matrix. The affinity-purified anti-4041 Ab was cross-linked to coupling gel with 5 M sodium 
cyanoborohydride, as instructed (Pierce). Patient PBL 5 cell lysate (60 microliters) was incubated, in duplicate samples, with the 
anti-HAP peptide (4041) Ab linked gel in a spin column for 2 hours at RT, then the columns washed four times, and bound pro-
teins eluted, as recommended (Pierce, Profound Mammalian Co-Immunoprecipitation Kit). Eluate fractions 1 and 2 from cell 
lysate samples that had been untreated (NT) or reduced and alkylated (D/I) were run in replicate on the same 4–20% tris-gly-
cine SDS-PAGE. The gel was split along a marker lane (Biorad) and then silver stained (Invitrogen silver staining kit). The mass 
marker lanes on either end of the gel are MultiMark multi-colored standards (Invitrogen). Molecular weights are in kilodaltons.Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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fer to a blot and washing. This capacity of antibody to rec-
ognize its antigen even following transfer to a blot from a
denaturing gel is demonstrated with Figure 7D, where the
rabbit anti-4041 antibodies (lane 1), but not control anti-
bodies (lanes 2,3) bind specifically to the biotin-labelled
4041 peptide, but not a control biotin-labelled 4040 pep-
tide (Figure 7D, compare lane 1 probed with 4041 peptide
as opposed to 4040 peptide). Four HIV+ individual's PBL
cell lysates, as well as a HIV negative PBL cell lysate control
were analyzed by gel electrophoresis and then immunob-
lotted with either rabbit anti-KLH or rabbit anti-4041
antibody (Figure 7A). A protein band migrating at 8.5
kDa, appeared to react with both biotin-labelled antibod-
ies and the interaction was judged to be non-specific
(open arrowhead, Figure 7A). However, only immunode-
tection with the biotin-labelled anti-4041 Ab revealed two
protein bands migrating at a molecular mass of 11.3 and
11.5 kDa from HIV positive PBL lysates, which were at the
predicted molecular mass for the two larger HIV-1 anti-
sense proteins of 105 and 108 aa in the wild-type virus
(Figure 7A, 7C, labelled HAPs). Further analysis of this
individual's HIV+ cell lysate proteins, run in replicate on
the same gel and then simultaneously immunoblotted,
showed that the 11.3/11.5 kDa species were recognized
with the biotin-labelled rabbit anti-4041 antibody or
AIDs antisera, but not normal sera, nor by control rabbit
p24 antiserum (Figure 7B). Control HIV-negative human
cell lysates (PBL 1) were also probed with the same anti-
body preparations and demonstrated no reactive bands at
11.3 or 11.5 kDa molecular mass (Figure 7E). However,
antibody detection using both a primary and secondary
labelled antibody universally had faint bands at 8–9 kDa
and 14 kDa (Figure 7E).
Reducing disulfide bonds in the HIV+ cell lysate sample
significantly removed the contribution of "non-specific"
bands and allowed prominent detection of the HAPs 11.3
and 11.5 kDa molecular mass species with the affinity-
purified antibody to the internal HIV antisense protein
epitope (Figure 7C, immunoblot with biotin-labelled
4041 Ab). As an additional control, we used the affinity-
purified antibody to the internal HAP epitope 4041 to
perform affinity-isolation of the same human HIV+ PBL
cell lysate. Once again the expected molecular mass bands
of 11.3 and 11.5 kDa were prominent on the silver-
stained gel, particularly when the eluate fractions were
reduced and alkylated (D/I, Figure 7F).
Discussion
This is the first demonstration of an antisense gene within
the human immunodeficiency virus type 1 (HIV-1) LTR
that functions to produce antisense protein(s) (HAPs)
and an antisense transcript that originates from an initia-
tor element in TAR region DNA, the HIVaINR (previously
described in U.S. patents 5,919,677 and 6,392,029). The
antisense transcript is intrinsically produced from the
human immunodeficiency virus LTR template, shown
both with in vitro transcription reactions and in vivo, in
cultured human cell lines that have had the HIV-1 LTR
sequences stably incorporated into the cellular chromo-
some (Figures 1C, 2B and additional File 2). Evidence is
provided that the antisense RNA has the potential to be
translated into protein(s) within human cells, including
human PBLs (Figures 3, 4, 5, 6, 7). The HIV-1 antisense
gene sequence corresponding to nucleotides 14–368 was
incorporated into a eukaryotic expression vector that
allowed addition of a carboxy terminal FLAG sequence
tag. The FLAG-tagged HIV-1 fusion proteins (HAP-
FLAG(s)) were then immunoaffinity purified on anti-
FLAG Ab resins or columns. Western blots confirmed that
the recombinant proteins, HAP-FLAG(s), form oligomers
that are recognized by AIDS sera, anti-FLAG antibody, and
antibody to an internal HAP peptide (anti-4041 Ab).
Finally, this same anti-4041 Ab specifically recognizes the
HAP wild-type species within HIV+ PBL cell lysates, but
not HIV-control cell lysates, and could isolate HAPs. Each
of these will be discussed in turn.
There are many remarkable aspects to this HIV-1 antisense
RNA. One of us (LBL) previously suggested that, because
of the potential for the beginning 25 nucleotides of the
antisense RNA initiated from the HIVaINR to overlap, and
form a complementary base-paired RNA duplex with the
5' end of HIV-1 sense transcripts, it could contribute to an
intrinsic RNA regulatory system for HIV transcription and
translation (see additional File 3 derived from U.S. patent
5,919,677). We suggested that the RNA duplex formation
could modulate the effective synthesis of HIV sense tran-
scripts by one or more mechanisms that might include
inhibiting or attenuating efficient RNA polymerase II
elongation of sense transcripts, altering the sense mRNA
stability or processing in the nucleus, or inhibiting cap site
function in initiation of translation (additional File 3 a-
d). We also previously showed that the HIVaINR antisense
RNA, when added to an HIV-1 LTR template linked to a
bacteriophage promoter, could effectively abrogate detec-
tion of sense HIV RNA transcripts in vitro even with T7
RNA polymerase driving the sense transcription (U.S. pat-
ent 5,919,677, example 1, Figure 3). At the time, the most
convincing models for naturally occurring antisense genes
directing synthesis of antisense RNA capable of directly
controlling gene expression were found in prokaryotes
[35]. More recently, the discovery of RNA silencing by
small interfering RNAs (siRNA), microRNAs (miRNAs),
and repeat-associated small interfering RNAs (rasiRNAs)
indicates that these small RNAs, 21–30 nucleotides in
length, can mediate effects in many species, and may rep-
resent a more universal approach to gene regulation [36-
41]. While the origins of the original dsRNA can vary from
hundreds of base-pairs in length (siRNAs) to a moreRetrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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unstructured transcript (primary-miRNA) containing
hairpin structures approximately 70 nt in length; [39]
both pathways are convergent following processing in the
nucleus and export to the cytoplasm. Both the processing
of the long dsRNA into siRNAs and the pre-miRNAs into
mature miRNAs require the dsRNA-specific endonuclease,
Dicer, acting in conjunction with a dsRNA-binding pro-
tein, the tar-RNA binding protein (TRBP) in humans
[39,42,43]. Subsequently, one of the small RNA strands in
the miRNA duplex is loaded onto Argonaute 2 (Ago2),
with the small RNA directing the cleavage of hundreds of
target molecules, if there is extensive complementary base
pairing of the small RNA to the target mRNA [39]. When
siRNAs/miRNAs base pair only partially with the mRNA
target, the function alters to blocking translation of the
mRNA into protein.
Here we would like to propose the hypothesis that the
HIVaINR antisense RNA, which has extensive secondary
structure by M-fold analysis (not shown) including multi-
ple stem-loop structures, might represent an intrinsic viral
primary miRNA, with the capability of forming miRNAs
directed to at least two major HIV-1 targets suggested by
the literature [44,45]. The first target, as we previously
proposed, would be the TAR RNA hairpin, which is
present in all HIV-1 mRNAs (as well as in HIV-1 genomic
RNA). The second target is additionally suggested by Ben-
nasser, Y., et al., in their computer-directed analysis and
identification of five candidate pre-miRNAs in HIV-1, and
is an extensive stem-loop structure found in the nef
mRNA[45]. The HIVaINR antisense RNA extends from the
HIVaINR (in R) through the U3 region overlapping the
nef gene ((additional File 1). It is exactly complementary
to the nef mRNA sequence shown in the predicted miRNA
precursor structure, is therefore also intrinsically capable
of forming similar secondary structures, but would have
the complementary sequence to nef mRNA and an exten-
sively base-pairing final miRNA product predicted. There-
fore, we would suggest that this may represent an intrinsic
mechanism used by HIV-1 to silence gene expression from
the HIV promoter in the absence of Tat protein, as well as
additionally and specifically from nef mRNA; Ago2
bound HIVaINR antisense RNA-derived guide miRNAs
directing cleavage at very specific sites in TAR RNA and nef
mRNA. The HIV-1 Tat protein, which binds to the sense
TAR RNA hairpin loop, as well as to the HIVaINR anti-
sense RNA (LBL, unpublished data), can presumably alter
the bound RNA secondary structures, such that the cleav-
age target is no longer accessible [46]. Tat protein, there-
fore, could be proposed to function as an anti-RNA
silencer, in addition to its many other capabilities. The
function of additional cellular TAR RNA binding proteins
such as TRBP in this context remains to be determined
[47]. These aspects will be focused on in more adequate
detail in a separate paper. In this paper, we simply wanted
to show that the HIV-1 LTR intrinsically produces an anti-
sense transcript that initiates from the region of the HIV-
aINR, and which also encodes proteins. Human
microRNAs can be derived from capped, polyadenylated
transcripts that also function as mRNAs, and we believe
that the HIVaINR antisense transcript also has the dual
capability to code for protein as well as function (once
processed) as miRNA[48].
Antisense RNA transcripts initiating from the region of the
HIVaINR were easily detectable using a sensitive biotin-
labelled RT-PCR that we developed (Figures 2 and addi-
tional File 2). We know that the RNA is initiated from the
region of the HIVaINR and not from spurious sites else-
where in the adjoining HIV-1 or cellular sequences,
because alternative primers used to detect DNA contami-
nation that would anneal to DNA slightly beyond the
antisense RNA initiation site revealed no RT-PCR product
(additional File 2). These results were confirmed by
primer extension and RNase digestion, using a non-radio-
active adaptation of both techniques that we developed
(Figure 1 and data not shown). This HIV antisense tran-
script initiating from HIVaINR (HIVaINR-antisense tran-
script) is in contrast to what has been described in HTLV-
1, where multiple initiation sites in the HTLV-1 3'LTR
have been observed[49]. HIV-1 sense transcripts are more
variably detectable, except when the RNA is obtained
from stably-transfected cells that have been stimulated
with calcium ionophore and PMA (Figure 2B). A low level
of HIV-1 sense transcripts is consistent with many other
studies suggesting that the HIV-1 promoter is regulated by
attenuation or inefficient elongation in the absence of
Tat[50].
Negative-strand RNA transcripts have previously been
described in HTLV-1 and the lentiviruses, HIV-1 and
feline immunodeficiency virus (FIV) [8,51-54]. A negative
strand promoter (NSP) had been previously localized
within the HIV-1 3' LTR U3 region[8]. This core NSP
extended from -78 to -172 (from the HIV cap site) and
corresponded to a region overlapping the NF-k B sites
(ibid). Negative-strand ORFs, such as ASO1 first described
by Miller[9], and the FIV antisense ORF and HIV-1 ASP
[53,54] were also described as overlapping (but of oppos-
ing polarity) to the envelope gene, which is located well
outside of the LTR in both FIV and HIV-1. Evidence for
this previously described HIV-1 antisense protein, the
ASP, was obtained by recognition of sera from HIV+, but
not HIV-individuals of the in vitro translated, 189 amino
acid, 19 kDa protein product[53]. It is of interest that both
the FIV and the ASP antisense RNAs contained sequence
complementary to both envelope and the highly-struc-
tured Rev-responsive element (RRE) [53-55]. This con-
trasts, however, with the HIV-1 antisense gene described
in this paper. The HIV antisense gene described in thisRetrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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paper is located in U3-R of the LTR, contains the HIVaINR
in TAR region DNA, and coding sequences that extend
from the region complementary to the TATA box region
through the U3 region, in the reverse orientation to the
coding sequences for the other HIV proteins (Figures 3, 4
and additional File 1). In addition, the HIVaINR antisense
RNA is complementary to the initial 25 nucleotide
sequence of TAR RNA, which includes the Tat protein
binding site. Inasmuch as both the 5'LTR and the 3'LTR
contain identical sequence, there is no known impedi-
ment for this gene to be active in both regions.
We chose to begin looking for the proteins translated off
the HIVaINR antisense RNA within human cells or
human cell lines, because human cells are the target of
HIV-1 infection, and the requirements for translation in
human cells, as opposed to a bacterial expression system,
can be very different. Another unique aspect of the HIV-1
antisense gene was the presence of stop codons within
each reading frame (Figures 3, 4). Isolation of the HIV-AS-
FLAG recombinant protein(s) indicates translational
decoding must be occurring through these presumptive
stop codons. The recombinant HIV-AS-FLAG vector was
transfected into HL2/3 cells, cell lysates were prepared,
and protein was purified using anti-FLAG affinity chroma-
tography (Figures 5, 6). Affinity-purified protein product
indicates two steps occurred: (1) an intact HIV-AS-FLAG
RNA was synthesized in vivo, in the transfected human
cells, and (2) translation of this recombinant HIV-1 anti-
sense RNA through the carboxyterminal FLAG sequences
occurred. The nucleotide sequence of the HIV-1 antisense
gene inserted into the recombinant vector was repeatedly
confirmed by sequencing, and both HAPs a (CUG start),
and b (AUG start) contained UGA codons (Figures 3 and
4). Western blotting confirmed production of protein(s)
containing the internal HAP epitope, in recombinant pro-
teins isolated using anti-FLAG Ab affinity resins (Figure
6). In addition, a <14 kDa molecular mass gel band was
removed from a denaturing gel (with affinity isolated
HIV-AS-FLAG recombinant proteins as in Figure 5C), sub-
jected to trypsin digestion, and the peptides analyzed by
matrix-assisted laser desorption ionization-mass spec-
trometry (MALDI-MS) (data not shown). This analysis
suggested that the predicted HAPs had been produced,
with one of the peptide mass "fingerprints" from the <14
kDa band confirming translation through a portion of the
FLAG epitope (Figure 3a and 3b, (11 aa) XXXX). Both the
internal HAP epitope 4041 and the carboxy-terminal
FLAG epitope present in HAPs a and b of the recombinant
proteins are downstream of the UGA codons. It is intrigu-
ing that UGA codons can potentially encode seleno-
cysteines, given the appropriate downstream secondary
RNA structure, called a selenocysteine insertion sequence
(SECIS)[30]. Eukaryotic selenoprotein synthesis requires
a functional SECIS element linked downstream of an
open reading frame: the specific sequence and structural
features of SECIS elements required for directing seleno-
cysteine incoroporation have been characterized[30]. We
note that exactly 125 nucleotides downstream of the ini-
tial UGA found in HAPs a (CUG start) is a potential hair-
pin structure beginning with the required 5'GUGA (SECIS
core), with a 9 bp lower stem (with bulges) and an adeno-
sine hairpin loop structure containing AAA with 3 bp in
the upper stem (see sequence below diagrammed 4041
peptide in Figure 4). However, the HIV-1 antisense RNA
lacks the 3' GA sequence found in the consensus SECIS
element structures, but instead contains a 3'GGG. RNA
hairpin secondary structure is also important in ribos-
omal frameshifting to create the full-length gag-pro-pol
precursor protein[56]. Regardless of the mechanism
employed to read-through or "decode", the experiments
outlined in this manuscript indicate that a translational
recoding process is occurring and results in protein prod-
uct(s). Translational decoding occurs in retroviruses, as
well as other organisms, as a mechanism to strictly regu-
late the amount of protein product produced[28,56].
Isolation of the HAPs protein products also presented
unique challenges. Expression of the HIV-1 antisense gene
products had profound consequences for the transfected
human Hela cell line, HL2/3. The eukaryotic vector CMV
promoter driving HIV-1 antisense gene expression pre-
sumably was more efficient than the intrinsic HIV anti-
sense promoter and led to accelerated cell death and
apoptosis. Therefore protein isolation had to occur within
a narrow time frame before the cells underwent apoptosis.
The phenomenon of enhanced syncytium formation and
apoptosis induced by the intrinsic HIV-1 antisense gene
transfection (over control transfections) is the subject of a
separate paper (U.S. patent 6,392,029 and data not
shown). The immunoaffinity-purified (and concentrated)
HIV-AS-FLAG recombinant proteins tended to oligomer-
ize such that larger species than the 13.7 kDa or 13.3 kDa
predicted for HAP-FLAG a or HAP-FLAG b following the
anti-FLAG Ab affinity column were observed. This may
have represented a function of the affinity purification uti-
lizing the FLAG epitope, as has been previously described
[32]. In addition some proteins tend to multimerize with
concentration [57]. However, the oligomeric form may
represent the functional form of the protein, as is sug-
gested by the recognition of the HAP-FLAG tetrameric
molecular mass species by AIDS sera (but not normal
sera) (Figure 5D). There are many proteins that require
oligomerization for function: transcription factors, TNF
receptor ligands, HIV-1 envelope with gp-41 trimer and
associated gp-120 trimer, to name a few [58]. There are a
number of motifs in the predicted amino acid sequence
that could facilitate interaction with other proteins,
including a proline rich region containing PXXPXR at the
amino-terminus in HAP b, and a leucine-rich regionRetrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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shared by HAPs a and b (Figure 4). Antibody to an inter-
nal HAP peptide (4041) recognized the expected molecu-
lar mass species in both HAP-FLAG transfected HL2/3
cells when the total cell lysate was examined (Figure 6,
lane 3, expected sizes 13.3, 13.7 kDa) and in HIV+ PBL
cell lysate (Figure 7A,B,C, expected sizes 11.3, 11.5 kDa),
which were not present in controls or uninfected PBL cell
lysates. Finally, immunoaffinity isolation of HIV+PBL
lysate proteins on a resin stably linked to an antibody to
the internal HAP peptide confirmed the expected molecu-
lar mass products of 11.3 kDa (HAP b) and 11.5 kDa
(HAP a) (Figure 7F). Again the appropriate size products
were apparent when the eluate sample was reduced and
alkylated (Figure 7F, lanes labeled D/I).
The location of this HIV-1 antisense gene suggests its
import in AIDS pathogenesis (see additional File 1). A
particular group of long-term survivors with HIV-1 infec-
tion were found to have an attenuated virus with deletions
in the Nef gene and the LTR [59]. The postulated original
viral deletion was believed to be in the region of the LTR,
which inspection reveals to be overlapping the HIV-1 anti-
sense gene (see additional File 1B, common SBBC dele-
tions: bracket at 9271–9317). Other studies have led to
conflicting results with respect to the importance of the
Nef gene[60,61]. Because the Nef gene overlaps the LTR
and also the region encoding the 73 carboxy-terminal
amino acids of HAPs, close inspection of the actual gene
deletions associated with either progression to AIDS or
nonprogression clearly reveals a line of demarcation with
respect to the HIV antisense gene and HAPs (see addi-
tional File 1C). In the Brambilla, et al study, they docu-
mented large deletions in Nef associated with AIDS
progression (but outside the HIV antisense gene coding
region)[60]. However, regions of deletion in Nef corre-
sponding to long term survival invariably included HAPs
sequence encoding the carboxy-terminal 10–20 amino
acids (please see additional File 1 detailing the genomic
regions deleted in long term survivors with respect to the
HAPs coding regions). It may be of interest that this car-
boxy-terminal sequence of the HIV antisense proteins
includes 9/22 amino acids sharing identity with paro-
myxoviral fusion proteins, as follows[62].
HAPs(a/b) PLLPYLAQLVLACSTIQRSVDI
Measles 437 PDAVYLHRIDLGPPISLERLDV 459 F1
SV5 VTYNSTIKLESSQILSIDPLDI
Sendai DATWGVQNLTVGPAIAIRPVDI
This would suggest that it is the previously unrecognized
HIV antisense gene that is vital therefore for AIDS progres-
sion.
Conclusion
A novel antisense gene within the HIV-1 LTR is described
that intrinsically produces RNA and proteins (HAPs) and
that may be of significance in AIDS pathogenesis. We
would suggest that this gene may be of interest as a new
target for vaccine development or AIDS intervention.
Methods
Human subjects and isolation of human peripheral blood 
lymphocytes (PBLs)
HIV + and HIV – blood donors were recruited from an
Infectious Disease Clinic at Buffalo General Hospital, after
informed consent, as approved by the institutional review
board (State University of New York at Buffalo). Blood
was diluted in Hank's balanced salt solution (HBSS)
(Gibco BRL), layered on top of Histopaque 1077 (Sigma),
and then centrifuged at 425 × g for 30 minutes at room
termperature. The peripheral blood mononuclear cell
(PBMC) layer was removed, washed three times with
HBSS, and then resuspended in serum-free X-vivo 15
media (BioWhittaker) for incubation in a plate at 37°C in
5% CO2. After two hours of incubation, non-adherent
cells were removed, washed in PBS, and then kept frozen
in liquid nitrogen until experimental use, as described
below. These cells were predominantly peripheral blood
lymphocytes (PBLs).
Cell lines, plasmids, and AIDS-specific reagents
The following reagents were obtained through the AIDS
Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH: pHIV-CAT plasmid containing HIV-1
LTR U3 and R sequences 5' to the chloramphenicol acetyl
transferase (CAT) gene from Drs. Gary Nabel and Neil Per-
kins[23]; the U38 and BF24 cell lines containing stably
integrated and silent copies of the HIV-1 LTR-CAT
sequences; the HL2/3 cell line containing stably inte-
grated copies of the HIV-1 molecular clone HXB2/3gpt
from Drs. Barbara K. Felber and George N. Pav-
lakis[24,31]; human HIV immunoglobulin (HIV-Ig), and
rabbit p24 antiserum.
In vitro transcription and RNA analysis
In vitro transcription reactions were performed with the
indicated HIV-1 LTR DNA templates (Figure 1B) and Dro-
sophila  nuclear extracts as a source of eukaryotic RNA
polymerases, as described by the manufacturer (Drosophila
Embryo Nuclear Extract Transcription System II,
Promega). The pooled and gel-purified DNA templates
were generated by PCR using primers containing specific
HIV-1 sequences (Figure 2A), as previously described
[63]. Each in vitro transcription reaction was performed
with 5 u Drosophila nuclear extract and the indicated DNA
template, in 7.5 mM HEPES, pH 7.6, 60 mM K glutamate,
3.75 mM MgCl2, 1.5 mM DTT, 3% glycerol, 0.5 mM each
rNTP, 2.5 µg/ml creatine kinase, 0.2 mM creatine phos-Retrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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phate, 6.25 µg/ml polyI poly C, and 10 u RNase inhibitor.
Following incubation for 1 hr at 22°C, the reaction mix-
tures were DNase I treated, phenol-chloroform extracted
and ethanol precipitated to purify the RNA synthesized in
vitro. Primer extension reactions using biotinylated HIV-1
specific primers (Figure 1B) and 3 u AMV reverse tran-
scriptase (RT) in a reaction buffer consisting of 50 mM
Tris pH 8.3, 50 mM KCl, 10 mM MgCl2, 10 mM DTT, 1
mM each dNTP, 0.5 mM spermidine, and 2.2 mM Na-
pyrophosphate were incubated for 60 min at 42°C[64]. A
nuclear extract control, in which in vitro transcription was
performed without added DNA template (no template;
NT), was also analyzed by primer extension with either a
sense primer (5'U3, Figure 1C, lane 4) or antisense primer
specific for HIV sequences (3'510–530, Figure 1C, lane
11), and verified the lack of contaminating template con-
tributed by the Drosophila nuclear extract or reaction com-
ponents. Biotinylated primers utlized in primer extension
reactions had the following sequences and are dia-
grammed in Figure 1B: 5' Ava I: TAATACGACTCACTAT-
AGGGTTTCGTCACATGG-CCCGAGAGC;
5'AvaII:TAATACGACTCACTATAGGGGCATGGGATGGA
GGACCCGGAG; 5'U3: TGGAAGGGCTAATTTGGTCC;
and 3'510–530; TAATACGACTCACTATAGGGTT ATT-
GAGGCTTAAGCAGTGG. (Additional, underlined
sequence represents T7 site). Complementary DNA prod-
ucts were analyzed following electrophoresis on a 6%
TBE-urea (denaturing PAGE) gel, transfer to Biodyne B
membranes (Pall), and colorimetric detection, as previ-
ously described[63].
Nonradioactive modification of RT-PCR and analysis of 
RNA synthesized in vivo
Human cell lines were expanded in culture with or with-
out stimulation for 2 hours with calcium ionophore
(A23187), 50 ng/ml, and phorbol myristate ester (PMA),
50 ng/ml. Total RNA was extracted from cells using TRIzol
(Gibco BRL Life Technologies), and equally divided for
separate treatments consisting of either two DNase I treat-
ments (75 u, Gibco), or two DNase I treatments plus
digestion with RNase A (70 µg/ml) and RNase TI (20 u),
as described (Boehringer Mannheim Biochemicals: RNase
Protection Kit). A proteinase K treatment (0.4 mg/ml) was
essential following the initial DNase treatment. Nucleic
acids were then purified by phenol-chloroform extraction
and ethanol precipitation. For antisense HIV-1 RNA
detection: the Ava1 primer complementary to antisense
RNA was utilized (5'TTTCGTCACATGGCCCGAGAGC 3')
during the reverse transcription step, then the Ava1 primer
and a biotinylated 441 primer(5'CCAGAGAGACCCAGTA
CAGGCAAAA3') were utilized during PCR. These primers
are illustrated in the context of the HIV antisense gene in
Figure 4. For sense HIV-1 RNA detection: an antisense
3'CAT primer (5'CAAGAATGTGAATAAAGGC 3') (or
alternatively 3'510–530 above) were used during RT, and
3'CAT (or 3'510–530) and biotinylated 5'472 primer
(5'CAGATCTGAGCCTGGGA 3') were used during PCR.
Reverse transcription was performed with 200 u MuLV-RT
and the indicated primer in a reaction mixture containing
10 mM Tris, pH 8.3, 50 mM KCL, 2.5 mM MgCl2, 1 mM
each dNTP, 40 u. RNase inhibitor, and 3 µl of the treated
RNA. The reaction mixture was then incubated for 35 min
at 42°C. PCR was performed, after adding the appropriate
biotinylated primer, 0.2 mM each dNTP, and 2.5 U Taq
DNA polymerase, for 30 cycles of denaturing, reannealing
and extension at 94°, 45 sec; 60°C, 45 sec; 72°C, 2 min.,
as described (Perkin Elmer, RNA PCR Core Kit). The RT-
PCR products were analyzed by 3% agarose gel electro-
phoresis, followed by transfer to Biodyne B membrane
and colorimetric detection, as previously described [63].
The internal standard (IS+) RNA was synthesized from a
DNA template containing the primer DNA sites used in
RT-PCR, and used in each RT-PCR to enable monitoring
of primer annealing efficiency and semi-quantitative com-
parison of different reaction mixtures. The DNA template
was constructed by a series of overlapping, PCR amplifica-
tion steps beginning with a core HIV-1 LTR template
extending from PvuII to HindIII restriction enzyme sites
(Figure 2A). Pooled PCR products were gel-purified, and
used as the template for the next PCR reaction, which
added in succession: AvaI and CAT primer sites, then T7-
5'G3PDH and Sp6-3'G3PDH primer sites (Figure 2A).
Either Sp6 RNA polymerase or T7 RNA polymerase was
used to synthesize in vitro the antisense IS+ RNA or sense
IS+ RNA standard, which was purified and quantitated
spectrophotometrically. The shorter IS+ RNA contained
the same primer sites used in RT-PCR, but yielded shorter
products: the HIV-1 antisense IS+ RNA RT-PCR product
was 59 bp, whereas the sense IS+ RNA RT-PCR product
was 80 bp. A titration of input IS+ RNA was included as a
control in each RT-PCR and analyzed along with the set of
cell-derived RNA samples, using the identical primers and
reaction components.
Cell transfection, lysis, and analysis of protein following 
immunoaffinity column purification
HL2/3 cells [31] were grown to near confluency in 100
mm plates (~8 × 106 cells) and transfected with either the
recombinant HIV-1 antisense gene-FLAG vector (HIV-AS-
FLAG); the opposite orientation-HIV-1 sequences within
the same vector (REV-FLAG) or empty vector (-) as a neg-
ative control; or a luciferase-FLAG vector as an additional
control using Transfectam, as described by the manufac-
turer (Promega). Following transfection and incubation
for 2 hr, complete media consisting of DMEM/F12 (Gibco
BRL), 10% fetal calf serum, penicillin-streptomycin, 1 ×
nonessential amino acids and anti-PPLO (Gibco BRL) was
added, along with Ca ionophore (50 ng/ml) and phorbol
myristate acetate (PMA, 50 ng/ml), and the transfectedRetrovirology 2006, 3:80 http://www.retrovirology.com/content/3/1/80
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cells were incubated overnight at 37°C in 5%CO2. Cells
were washed in Tris-buffered saline supplemented with 1
mM CaCl2, and lysed with 1 ml lysis buffer per dish. Lysis
buffer contained 25 mM Tris pH 7.4, 150 mM NaCl, 1
mM CaCl2, 1% Triton X-100, 27 µg/mL aprotinin, 10 µg/
mL leupeptin, and 100 mM PMSF). Following incubation
on ice for 30 min, cells were scraped, transferred to micro-
tubes and spun at 15,400 × g to pellet cell debris. The
cleared lysates from each set of transfections were purified
over individual mouse monoclonal anti-FLAG M2 affinity
columns, and eluted with 0.1 M glycine (pH 3.5), per the
manufacturer (Sigma). Pooled eluates were concentrated
in dialysis tubing (MWCO = 500) by packing in PEG
8000, and were then analyzed on Tris-tricine-urea PAGE
gels with or without treatment with dithiothreitol (DTT)
or DTT and iodoacetamide (D/I) [33]. Gels were electrob-
lotted onto nitrocellulose membranes using an Xcell II
blot module (Novex). The blots were blocked in either 1%
BSA (for anti-FLAG Ab detection), 3% BSA/0.05% Tween-
20 in TBS (for biotin-labeled anti-peptide antibody detec-
tion), or 5% non-fat dried milk/1% BSA, then directly
probed with either biotinylated anti-FLAG M2 antibody
(Stratagene), biotin-labeled rabbit anti-peptide antibody
(Biosource), or indirectly probed with HIV-Ig (antisera) or
normal sera, followed by biotinylated goat anti-human
immunoglobulin (Fab2) (Biosource). Normal mouse sera
was added to the immunodetection steps with human
sera. Colorimetric detection of the blots was then per-
formed, as described [63-65].
Construction of recombinant HIV antisense gene-FLAG 
and REV-FLAG vectors
HIV-1 antisense gene sequences derived from pHIV-
CAT[23] were generated by PCR, gel-purified, and cloned
into pTarget, as described by the manufacturer (Promega).
The inserted sequences were digested with BamH1 (site
contributed by pTarget) and EcoRV, gel purified, and
directionally subcloned into the pCMV-Tag4A vector
(Stratagene) that had also been digested with BamH1 and
EcoRV and gel-purified, using standard methods [64]. The
recombinant HIV antisense gene-FLAG vector contains
the CMV immediate early promoter upstream of the HIV
antisense gene sequence, but no translation start signal
except that intrinsic to the HIV antisense gene. In addi-
tion, the HIV antisense gene is linked to 9 amino acid
sequences contributed by the vector in frame with the car-
boxy-terminal FLAG (DYKDDDDK) sequences and termi-
nation signals. REV-FLAG contains the identical HIV
antisense gene insert sequences, but in the reverse orienta-
tion, within the pCMV-Tag 4A vector. Recombinant vector
sequences were confirmed by sequencing.
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